DexCom Inc (DXCM)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$81.97
Buy
$82.03
$1.725 (+2.15%)
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Prices updated at 06 May 2025, 20:27 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Most recent dividend payment
| - | |
| - | |
| - | |
| - | |
| - | |
| - |
Total dividend yield
Dividend history and forecast data table
| Year | Dividend per share | Dividend growth (%) |
|---|---|---|
| 2025 | - | - |
| 2024 | - | - |
| 2023 | - | - |
| 2022 | - | - |
| 2021 | - | - |
| 2020 | - | - |
| 2019 | - | - |
| 2018 | - | - |
| 2017 | - | - |
| 2016 | - | - |
Total dividend yield data table
| Year | Dividend yield (%) | Buyback yield (%) | Total yield (%) |
|---|---|---|---|
| 2025 | - | 2.58 | 2.58 |
| 2024 | - | 4.02 | 4.02 |
| 2023 | - | 0.34 | 0.34 |
| 2022 | - | 1.22 | 1.22 |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | 0.44 | 0.44 |
| 2018 | - | - | - |
| 2017 | - | - | - |
| 2016 | - | - | - |
Dividend per share
No data available
% of earnings paid to shareholders
No data available
Dividend per share data table
| Year | Dividend per share |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
% of earnings paid to shareholders data table
| Year | Payout ratio (%) |
|---|---|
| 2025 | - |
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | - |
| 2019 | - |
| 2018 | - |
| 2017 | - |
| 2016 | - |
Latest Financial Report as of 05 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.
